Literature DB >> 18066645

Use of the pericardial cord as a substitute for an infected mitral prosthetic ring associated with aortic prosthetic valve endocarditis.

Katsuhiko Matsuyama1, Wataru Katou, Yuichi Ueda.   

Abstract

We report the case of a 61-year-old man with prosthetic valve endocarditis after both aortic valve replacement and mitral annuloplasty. Necrotic tissue and dehiscence of the suture line in the aortic annulus were found, and the infection extended to the anterior portion of the mitral prosthetic ring. The autologous pericardial cord was used as a substitute for the infected mitral prosthetic ring, and aortic root replacement was performed with a stentless bioprosthesis. The autologous pericardial cord was useful as a substitute for an infected mitral prosthetic ring.

Entities:  

Mesh:

Year:  2007        PMID: 18066645     DOI: 10.1007/s11748-007-0179-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  4 in total

1.  Seven years' experience with suture annuloplasty for mitral valve repair.

Authors:  Tayfun Aybek; Petar Risteski; Aleksandra Miskovic; Andreas Simon; Selami Dogan; Ulf Abdel-Rahman; Anton Moritz
Journal:  J Thorac Cardiovasc Surg       Date:  2006-01       Impact factor: 5.209

2.  Valvuloplasty with glutaraldehyde-treated autologous pericardium in patients with complex mitral valve pathology.

Authors:  C K Ng; J Nesser; C Punzengruber; O Pachinger; J Auer; H Franke; P Hartl
Journal:  Ann Thorac Surg       Date:  2001-01       Impact factor: 4.330

3.  Mitral valve repair for degenerative disease: is pericardial posterior annuloplasty a durable option?

Authors:  Stefano Bevilacqua; Alfredo Giuseppe Cerillo; Jacopo Gianetti; Umberto Paradossi; Massimiliano Mariani; Sacha Matteucci; Enkel Kallushi; Mattia Glauber
Journal:  Eur J Cardiothorac Surg       Date:  2003-04       Impact factor: 4.191

4.  Posterior pericardial annuloplasty: a physicological correction?

Authors:  M Salati; R Scrofani; C Santoli
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.